OKT3/antithymocyte globulin immunoprophylaxis in the prevention of recurrence of acute vanishing bile duct syndrome in retransplanted patients

Transplant Proc. 1994 Dec;26(6):3701-5.
No abstract available

MeSH terms

  • Acute Disease
  • Antilymphocyte Serum / therapeutic use*
  • Bile Duct Diseases / prevention & control*
  • Follow-Up Studies
  • Graft Rejection / prevention & control*
  • Graft Rejection / therapy
  • Humans
  • Incidence
  • Liver Function Tests
  • Liver Transplantation / immunology*
  • Liver Transplantation / physiology
  • Methylprednisolone / therapeutic use
  • Muromonab-CD3 / therapeutic use*
  • Postoperative Complications / epidemiology
  • Recurrence
  • Reoperation
  • Syndrome
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Muromonab-CD3
  • Methylprednisolone